SLU Researchers Enrolling Participants in Flu Vaccine Clinical Trial
January 05, 2023
January 05, 2023
HILLSBORO, Missouri, Jan. 5 (TNSres) -- St. Louis University issued the following news:
By Carrie Bebermeyer, Public Relations Director
Saint Louis University's Center for Vaccine Development is participating in a clinical study for an investigational vaccine being developed against influenza developed by Pfizer, which is funding this research.
While there are licensed vaccines and treatments for influenza, the current vaccines are only about 50% effective . . .
By Carrie Bebermeyer, Public Relations Director
Saint Louis University's Center for Vaccine Development is participating in a clinical study for an investigational vaccine being developed against influenza developed by Pfizer, which is funding this research.
While there are licensed vaccines and treatments for influenza, the current vaccines are only about 50% effective . . .